Protein L Products

Purity: ≥95%, by SDS-PAGE visualized with Coomassie® Blue Staining.Description:Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been

Purity: ≥95%, by SDS-PAGE visualized with Coomassie® Blue Staining.Description:Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been

Purity: ≥95%, by SDS-PAGE visualized with Coomassie® Blue Staining.Description:Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been

Cell Line Origin Human Caucasian B Cell Lymphoma Cell Line Description Human lymphoblastoid cell line Culture Medium RPMI 1640 + 4mM Glutamine + 10% Foetal Bovine Serum (FBS). Subculture Routine Maintain cultures between 3-9x100,000 cells/ml 5% CO

General description SILu &#8482: Lite CRP is a recombinant human protein expressed in human 293 cells. It is a protein consisting of 226 amino acids (including a C-terminal polyhistidine and FLAG &#174: tags), with a calculated molecular weight

Cell Line Origin Human lymphoblast Cell Line Description Derived from the human lymphoblast TK6, which is heterozygous for TK. The parent line was exposed to 20ug/ml thioguanine which produced a thioguanine resistant sub-population.

Cell Line Origin Mouse B cell lymphoma Cell Line Description Expresses surface IgM but does not secrete Ig. Secretion of IgM can be induced with LPS.

Cell Line Origin Mouse B cell lymphoma Cell Line Description Derived from a tumour induced in an NZC mouse by irradiation, the cell line represents an early stage of B cell development characterised by high-density membrane immunoglobulin

Cell Line Origin Human Caucasian B lymphocyte Cell Line Description A non Ig-secreting, HAT sensitive, 6-thioguanine resistant, human B lymphocyte. Derived from the parent line WIL2.

Biochem/physiol Actions YMU1 is a cell-permeable and nontoxic inhibitor of hTMPK (thymidylate kinase) that sensitizes tumor cells to doxorubicin in vitro and in vivo . Features and Benefits This compound is a featured product for Apoptosis

Biochem/physiol Actions YMU1 is a cell-permeable and nontoxic inhibitor of hTMPK (thymidylate kinase) that sensitizes tumor cells to doxorubicin in vitro and in vivo . Features and Benefits This compound is a featured product for Apoptosis

Cell Line Origin Not specified Cell Line Description The antibody is directed against epitope B of the L3T4 antigen. This antigen is the murine equivalent of CD4.